FDA Orange Book · active-ingredient family
Misoprostol
Misoprostol is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:CYTOTEC · NDA 019268
1
Brand (NDA)
4
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CYTOTECRLD×2 | PFIZER | NDA 019268 | AB | Sep 21, 1990 |
Generic (ANDA) products (4)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MISOPROSTOL×2 | MICRO LABS | ANDA 216872 | AB | Oct 17, 2022 | |
| MISOPROSTOL×2 | ACQ PHARMA | ANDA 210201 | AB | Jul 02, 2019 | |
| MISOPROSTOL×2 | NOVEL LABS INC | ANDA 091667 | — | Jul 25, 2012 | |
| MISOPROSTOL×2 | ANI PHARMS | ANDA 076095 | AB | Jul 10, 2002 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Misoprostol — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

